0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Editorial | 
Charles L. Campbell, MD; David J. Moliterno, MD
JAMA. 2015;313(8):801-802. doi:10.1001/jama.2015.0567.

Original Investigation | 
Anne-Marie Schjerning Olsen, MD, PhD; Gunnar H. Gislason, MD, PhD; Patricia McGettigan, MD; et al.
JAMA. 2015;313(8):805-814. doi:10.1001/jama.2015.0809.
Includes: Supplemental Content

Original Investigation | 
Barthelemy Diouf, PharmD, PhD; Kristine R. Crews, PharmD; Glen Lew, MD; et al.
JAMA. 2015;313(8):815-823. doi:10.1001/jama.2015.0894.
Includes: Supplemental Content

Viewpoint | 
Marc B. Garnick, MD
JAMA. 2015;313(6):563-564. doi:10.1001/jama.2014.17334.

Viewpoint | 
Muthiah Vaduganathan, MD, MPH; Vinay Prasad, MD, MPH
JAMA. 2014;312(24):2619-2620. doi:10.1001/jama.2014.15221.
Includes: Supplemental Content

Viewpoint | 
Paul C. Mullan, MD, MPH; David O. Kessler, MD, MSc; Adam Cheng, MD, FRCPC
JAMA. 2014;312(22):2333-2334. doi:10.1001/jama.2014.15741.

Original Investigation |  FREE
Lana A. Castellucci, MD; Chris Cameron, MSc; Grégoire Le Gal, MD, PhD; et al.
JAMA. 2014;312(11):1122-1135. doi:10.1001/jama.2014.10538.
Includes: Supplemental Content

JAMA Patient Page |  FREE
Jill Jin, MD, MPH
JAMA. 2014;312(11):1167. doi:10.1001/jama.2014.2078.
Includes: Supplemental Content

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2014;312(9):955-957. doi:10.1001/jama.2014.10644.

Review |  FREE
Anita Kohli, MD, MS; Ashton Shaffer, BA; Amy Sherman, MD; et al.
JAMA. 2014;312(6):631-640. doi:10.1001/jama.2014.7085.
Includes: CME, Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Internal Medicine
Original Investigation  | 
Rates of Opioid Dispensing and Overdose After Introduction of Abuse-Deterrent Extended-Release Oxycodone and Withdrawal of Propoxyphene
Marc R. Larochelle, MD, MPH; Fang Zhang, PhD; Dennis Ross-Degnan, ScD; et al.
JAMA Ophthalmology
Original Investigation  | 
Additive Intraocular Pressure–Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost:  A Report of 2 Randomized Clinical Trials
Hidenobu Tanihara, MD; Toshihiro Inoue, MD; Tetsuya Yamamoto, MD; et al.
JAMA Oncology
Original Investigation  | 
Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone:  Analyses of Data From 2 Women’s Health Initiative Randomized Clinical Trials
Rowan T. Chlebowski, MD, PhD; Thomas E. Rohan, PhD; JoAnn E. Manson, MD, DrPH; et al.
JAMA Oncology
Special Communication  | 
Patient-Reported Outcomes in Cancer Drug Development and US Regulatory Review:  Perspectives From Industry, the Food and Drug Administration, and the Patient
Ethan Basch, MD, MSc; Cindy Geoghegan, BA; Stephen Joel Coons, PhD; et al.